Sunday, November 1, 2026

Kim Jong Un Orders Surge in Artillery Shell Production

Kim Jong Un emphasizes artillery shell production and modernization of munitions to enhance military readiness and support economic goals.

China’s Bold Claim: 44 Gold Medals After Adding Taiwan and Hong Kong—But Did They Really Win?

Chinese people are countering this by combining the medal counts of Hong Kong and Taiwan, which would make them 44 gold medals.

Nadal and Alcaraz to Represent Spain in Paris Olympics Doubles

Rafael Nadal and Carlos Alcaraz, the new and old Spanish tennis kings, will compete in men's doubles at the 2024 Paris Olympics.

News1

Author's Latest

Celtrion’s Steqeyma Seizes 16% Market Share in the U.S.: What’s Next for This Autoimmune Treatment?

Celltrion's autoimmune drug Steqeyma surpasses 16% market share in the U.S., accelerating prescription growth and expansion.

Yuhan Corp. Signs $874 Million API Supply Deal With Global Pharmaceutical Company

Yuhan Corp. has secured a long-term active pharmaceutical ingredient supply contract worth $874 million with a global pharmaceutical company, expanding its overseas export business.

Pharos iBio and Kolon Pharmaceutical Expand Joint Development of Lung Cancer Drug

Pharos iBio and Kolon Pharmaceutical are stepping up development of PHI-701, a next-generation EGFR inhibitor targeting patients who have developed resistance to existing targeted lung cancer treatments.

Rokit Healthcare Secures Singapore Patent for Skin Regeneration Patch Technology

Rokit Healthcare has secured a Singapore patent for a personalized skin regeneration patch technology and plans to use the country as a base for expanding into Southeast Asia’s regenerative medicine market.

Samsung Seoul Hospital Performs 1 in 5 Gastric Cancer Surgeries With Robots

Samsung Seoul Hospital has performed 1,500 cumulative robotic gastric cancer surgeries, with robot-assisted procedures accounting for 22% of all gastric cancer surgeries last year.

Alteogen Signs Subcutaneous Injection Development Deal With Novartis Worth Up to $3.22 Billion

Alteogen has signed an option and licensing agreement with Novartis to develop and commercialize subcutaneous formulations based on its ALT-B4 technology, with potential payments of up to $3.22 billion plus royalties.

How Mediwhale’s Dr. Noon CVD Uses AI to Revolutionize Cardiovascular Risk Assessment

Mediwhale presents clinical applications of retinal image analysis for cardiovascular risk assessment at the European Cardiology Congress.

JAYJUN Wins China’s No. 1 Mask Pack Brand of the Year for 10th Consecutive Year

JAYJUN has retained the top spot in China’s mask pack category for 10 consecutive years and received the Masterpiece award recognizing its decade-long winning streak.

SK Biopharmaceuticals Introduces 128 NVIDIA B200 GPUs, Accelerating AI-Driven Drug Discovery

SK Biopharmaceuticals has secured 128 NVIDIA B200 GPUs to build large-scale AI infrastructure, accelerate AI-driven drug discovery, strengthen TR-AX, and explore new AI-based research business models.

Asia MSD Applies for Fast-Track Listing Pilot Program for Pulmonary Arterial Hypertension Drug Winrevair

Asia MSD has applied to a government fast-track listing pilot program aimed at accelerating National Health Insurance coverage for Winrevair, a novel pulmonary arterial hypertension treatment.

“Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target

Celltrion is expected to outperform its first-half results in the second half, driven by new-product growth, European tender wins and stronger demand for high-margin products, potentially allowing it to exceed its full-year targets.

South Korea Begins Its First Advanced Regenerative Medicine Treatment Using ViGenCell Therapy

ViGenCell’s VT-EBV-N has begun South Korea’s first approved advanced regenerative medicine treatment, giving patients with high-risk EBV-positive lymphoma access to a personalized T-cell therapy while generating real-world clinical and manufacturing data.

Unlocking the Future: How Ericsson’s AI-RAN and ISAC Technologies Are Shaping 6G Networks

Ericsson unveils next-gen network technologies aimed at the AI era, highlighting advancements in global telecommunications.

Discover the Enhanced Master V9 2027: 29 Massage Modes for Ultimate Spine Care

Ceragem has launched the Master V9 2027, expanding massage modes to 29 and enhancing heat, reclining features, and usability.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.